Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

MNPRMNPR
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in MONOPAR THERAPEUTICS INC

CITADEL ADVISORS LLC holds 37,004 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $3.4M as of 2026-Q2. The position was decreased (-36.7% shares). MNPR represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$3.4M

Current Shares

37,004

Total Value Change

+$3.2M

Total Shares Change

+30,772

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
37,004
-36.7%
$3.4M0.0%$92.59
0
2026-Q1
Increased
58,436
+1051.9%
$3.2M0.0%$51.88
43
2025-Q4
New
5,073
-
$331,2670.0%$65.07
36
2025-Q3
Exited
0
-100.0%
$00.0%$75.90
0
2025-Q2
New
6,232
-
$222,9810.0%$33.60
35

Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used